Global OTC Artificial Tears Market Segment Research Report 2024
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global OTC Artificial Tears Market Segment Research Report 2022》, which aims to sort out the development status and trends of the OTC Artificial Tears industry at home and abroad, estimate the overall market scale of the OTC Artificial Tears industry and the market share of major countries, OTC Artificial Tears industry, and study and judge the downstream market demand of OTC Artificial Tears through systematic research, Analyze the competition pattern of OTC Artificial Tears, so as to help solve the pain points of various stakeholders in OTC Artificial Tears industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of OTC Artificial Tears Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in OTC Artificial Tears Market?
OcuSoft
Santen Pharmaceutical Co. Ltd
Johnson and Johnson
Bausch and Lamb
Alcon
Similasan Corporation
Akorn, Inc.
Sun Pharmaceutical Industries Limited
AbbVie, Inc.
Ursapharm Arzneimittel GmbH
Major Type of OTC Artificial Tears Covered in XYZResearch report
Preservative Based
Non-preservative Based
Application Segments Covered in XYZResearch Market
Hospital Pharmacies
Drug Stores
Online
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global OTC Artificial Tears Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global OTC Artificial Tears Market by Value
2.2.1 Global OTC Artificial Tears Revenue by Type
2.2.2 Global OTC Artificial Tears Market by Value (%)
2.3 Global OTC Artificial Tears Market by Production
2.3.1 Global OTC Artificial Tears Production by Type
2.3.2 Global OTC Artificial Tears Market by Production (%)
3. The Major Driver of OTC Artificial Tears Industry
3.1 Historical & Forecast Global OTC Artificial Tears Demand
3.2 Largest Application for OTC Artificial Tears (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional OTC Artificial Tears Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of OTC Artificial Tears Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US OTC Artificial Tears Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe OTC Artificial Tears Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China OTC Artificial Tears Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan OTC Artificial Tears Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India OTC Artificial Tears Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea OTC Artificial Tears Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia OTC Artificial Tears Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global OTC Artificial Tears Average Price Trend
12.1 Market Price for Each Type of OTC Artificial Tears in US (2018-2022)
12.2 Market Price for Each Type of OTC Artificial Tears in Europe (2018-2022)
12.3 Market Price for Each Type of OTC Artificial Tears in China (2018-2022)
12.4 Market Price for Each Type of OTC Artificial Tears in Japan (2018-2022)
12.5 Market Price for Each Type of OTC Artificial Tears in India (2018-2022)
12.6 Market Price for Each Type of OTC Artificial Tears in Korea (2018-2022)
12.7 Market Price for Each Type of OTC Artificial Tears in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 OTC Artificial Tears Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of OTC Artificial Tears
14. OTC Artificial Tears Competitive Landscape
14.1 OcuSoft
14.1.1 OcuSoft Company Profiles
14.1.2 OcuSoft Product Introduction
14.1.3 OcuSoft OTC Artificial Tears Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Santen Pharmaceutical Co. Ltd
14.2.1 Santen Pharmaceutical Co. Ltd Company Profiles
14.2.2 Santen Pharmaceutical Co. Ltd Product Introduction
14.2.3 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Johnson and Johnson
14.3.1 Johnson and Johnson Company Profiles
14.3.2 Johnson and Johnson Product Introduction
14.3.3 Johnson and Johnson OTC Artificial Tears Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Bausch and Lamb
14.4.1 Bausch and Lamb Company Profiles
14.4.2 Bausch and Lamb Product Introduction
14.4.3 Bausch and Lamb OTC Artificial Tears Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Alcon
14.5.1 Alcon Company Profiles
14.5.2 Alcon Product Introduction
14.5.3 Alcon OTC Artificial Tears Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Similasan Corporation
14.6.1 Similasan Corporation Company Profiles
14.6.2 Similasan Corporation Product Introduction
14.6.3 Similasan Corporation OTC Artificial Tears Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Akorn, Inc.
14.7.1 Akorn, Inc. Company Profiles
14.7.2 Akorn, Inc. Product Introduction
14.7.3 Akorn, Inc. OTC Artificial Tears Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Sun Pharmaceutical Industries Limited
14.8.1 Sun Pharmaceutical Industries Limited Company Profiles
14.8.2 Sun Pharmaceutical Industries Limited Product Introduction
14.8.3 Sun Pharmaceutical Industries Limited OTC Artificial Tears Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 AbbVie, Inc.
14.9.1 AbbVie, Inc. Company Profiles
14.9.2 AbbVie, Inc. Product Introduction
14.9.3 AbbVie, Inc. OTC Artificial Tears Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Ursapharm Arzneimittel GmbH
14.10.1 Ursapharm Arzneimittel GmbH Company Profiles
14.10.2 Ursapharm Arzneimittel GmbH Product Introduction
14.10.3 Ursapharm Arzneimittel GmbH OTC Artificial Tears Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of OTC Artificial Tears Industry (Volume)
Figure 2. OTC Artificial Tears Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by OTC Artificial Tears Revenue in 2022
Figure 5. US OTC Artificial Tears Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe OTC Artificial Tears Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China OTC Artificial Tears Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan OTC Artificial Tears Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India OTC Artificial Tears Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea OTC Artificial Tears Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia OTC Artificial Tears Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. OTC Artificial Tears Revenue, by Type (Million USD) (2018-2028)
Table 4. OTC Artificial Tears Production, by Type (K Unit) (2018-2028)
Table 5. OTC Artificial Tears Demand (K Unit) by Application (2018-2028)
Table 6. OTC Artificial Tears Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top OTC Artificial Tears Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia OTC Artificial Tears Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of OTC Artificial Tears in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. OcuSoft Profiles
Table 61. OcuSoft OTC Artificial Tears Product Introduction
Table 62. OcuSoft OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. OcuSoft Strategic initiatives
Table 64. Santen Pharmaceutical Co. Ltd Profiles
Table 65. Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Introduction
Table 66. Santen Pharmaceutical Co. Ltd OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Santen Pharmaceutical Co. Ltd Strategic initiatives
Table 68. Johnson and Johnson Profiles
Table 69. Johnson and Johnson OTC Artificial Tears Product Introduction
Table 70. Johnson and Johnson OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Johnson and Johnson Strategic initiatives
Table 72. Bausch and Lamb Profiles
Table 73. Bausch and Lamb OTC Artificial Tears Product Introduction
Table 74. Bausch and Lamb OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Bausch and Lamb Strategic initiatives
Table 76. Alcon Profiles
Table 77. Alcon OTC Artificial Tears Product Introduction
Table 78. Alcon OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Alcon Strategic initiatives
Table 80. Similasan Corporation Profiles
Table 81. Similasan Corporation OTC Artificial Tears Product Introduction
Table 82. Similasan Corporation OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Similasan Corporation Strategic initiatives
Table 84. Akorn, Inc. Profiles
Table 85. Akorn, Inc. OTC Artificial Tears Product Introduction
Table 86. Akorn, Inc. OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Akorn, Inc. Strategic initiatives
Table 88. Sun Pharmaceutical Industries Limited Profiles
Table 89. Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Introduction
Table 90. Sun Pharmaceutical Industries Limited OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Sun Pharmaceutical Industries Limited Strategic initiatives
Table 92. AbbVie, Inc. Profiles
Table 93. AbbVie, Inc. OTC Artificial Tears Product Introduction
Table 94. AbbVie, Inc. OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. AbbVie, Inc. Strategic initiatives
Table 97. Ursapharm Arzneimittel GmbH Profiles
Table 98. Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Introduction
Table 99. Ursapharm Arzneimittel GmbH OTC Artificial Tears Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Ursapharm Arzneimittel GmbH Strategic initiatives
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices